Updates are available Correction dated 2025-01-08
Click to view Correction: https://doi.org/10.1186/s12348-024-00450-w
-
Authors
Pleyer, Uwe
Pavesio, Carlos
Miserocchi, Elisabetta
Heinz, Carsten
Devonport, Helen
Llorenç, Víctor
Burke, Tomás
Nogueira, Vanda
Kodjikian, Laurent
Bodaghi, Bahram
-
Funding
Funding for this research was provided by:
Alimera Sciences
Charité - Universitätsmedizin Berlin
- License Information
-
More Information
Article History
Received: 24 October 2023
Accepted: 2 May 2024
First Online: 30 May 2024
Change Date: 8 January 2025
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/s12348-024-00450-w
Declarations
:
: Not relevant.
: Due to the characteristics of this study, informed consent was not required.
: All authors were remunerated for their contributions to the advisory board by Alimera Sciences.Carsten Heinz: Consultancy: Alimera; Lectures: Alimera Science, Biogen, Bayer, Novartis.Tomas Burke: Advisory Board: Roche, Bayer; Educational Grant: Bayer.Speaker fee: Alimera Sciences, Allergan, Bayer, Cardiff University, Novartis, Royal College of Optometrists, Scope OphthalmicsPayment of fees for open access publication: Alimera Sciences.None of the authors have received any payment for the current paper. Carlos Pavesio, Uwe Pleyer, and Bahram Bodaghi are co-authors of this paper and editorial board members of the journal. They have not been involved during the review process. The rest of the authors have no conflict of interest to declare.
